Nonhematologic toxicities during course 1
. | . | Toxicity grade . | . | . | . | |||
|---|---|---|---|---|---|---|---|---|
. | No. of patients . | 1 . | 2 . | 3 . | 4 . | |||
| VPA dose, mg/kg | ||||||||
| 20 | 3 | 2 | 1 | 0 | 0 | |||
| 35 | 9 | 1 | 6 | 2 | 0 | |||
| 50 | 10 | 0 | 7 | 2 | 0 | |||
| Phase 2, 50 mg/kg | 32 | 5 | 16 | 8 | 1 | |||
. | . | Toxicity grade . | . | . | . | |||
|---|---|---|---|---|---|---|---|---|
. | No. of patients . | 1 . | 2 . | 3 . | 4 . | |||
| VPA dose, mg/kg | ||||||||
| 20 | 3 | 2 | 1 | 0 | 0 | |||
| 35 | 9 | 1 | 6 | 2 | 0 | |||
| 50 | 10 | 0 | 7 | 2 | 0 | |||
| Phase 2, 50 mg/kg | 32 | 5 | 16 | 8 | 1 | |||